China Oral Industry Group Holdings Limited 中國口腔產業集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰8406） 內幕消息 清盤呈請 本 公 佈 乃 由 中 國 口 腔 產 業 集 團 控 股 有 限 公 司（「本公司」）根 據 香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）GEM證 券 上 市 規 則（「GEM上市規則」）第17.10條及香港法例 第571章證券及期貨條例第XIVA部 項 下 之 內 幕 消 息 條 文（定 義 見GEM上 市 規 則） 作 出。 清盤呈請 本公司於2025年2月5日 收 到 由 安 業 財 經 印 刷 有 限 公 司（「呈請人」）向 香 港 特 別 行 政 區 高 等 法 院（「高等法院」）提 交 的 清 盤 呈 請（「呈 請」），涉 及 本 公 司 截 至2024年 12月31日逾期未付款項總額541,150.00港元及利息167,037.59港 元。 本 公 司 正 在 尋 求 法 律 意 見，以 確 定 就 該 呈 請 採 取 的 可 能 行 動，以 保 護 公 司 及 其 股 東 的 整 體 利 ...

公司名稱： 中國口腔產業集團控股有限公司 呈交日期： 2025年1月24日 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 08406 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | 已發行股份 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 本 公 告 僅 供 參 考，並 不 構 成 收 購、購 買 或 認 購 中 國 口 腔 產 業 集 團 控 股 有 限 公 司 證 券 之 邀 請 或 要 約。 China Oral Industry Group Holdings Limited 中國口腔產業集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰8406） 完成根據一般授權認購新股份 認購事項之所得款項淨額約為31,720,000港元。本公司擬將所得款項淨額(i)63.05% （相 當 於 約20,000,000港 元）用 於 本 集 團 的 潛 在 收 購 或 投 資 機 會；及(ii)36.95%（相 當於約11,720,000港 元）用 於 本 集 團 之 一 般 營 運 資 金。 – 1 – 認購事項完成後對本公司股權架構的影響 下 文 載 列 本 公 司 於 緊 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 本 公 告 僅 供 參 考，並 不 構 成 收 購、購 買 或 認 購 中 國 口 腔 產 業 集 團 控 股 有 限 公 司 證 券 之 邀 請 或 要 約。 China Oral Industry Group Holdings Limited 誠 如 該 公 告 所 披 露，認 購 協 議 的 最 後 截 止 日 期 為 二 零 二 四 年 十 二 月 三 十 一 日。 由 於 需 要 更 多 時 間 達 成 認 購 協 議 項 下 的 若 干 條 件，本 公 司 與 認 購 方 於 二 零 二 四 年 十 二 月 三 十 日 訂 立 補 充 協 議，以 延 長 最 後 截 止 日 期 至 二 零 二 五 年 一 月 二 十 四 日。 除 上 述 延 長 最 後 截 止 日 期 外，認 購 協 議 的 所 有 其 他 條 款 均 維 持 不 變 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 本 公 告 僅 供 參 考，並 不 構 成 收 購、購 買 或 認 購 中 國 口 腔 產 業 集 團 控 股 有 限 公 司 證 券 之 邀 請 或 要 約。 China Oral Industry Group Holdings Limited 中國口腔產業集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰8406） 根據一般授權認購新股份 認購股份相當於(i)本公告日期本公司現有已發行股本約20.00%；及(ii)假設本 公 司 已 發 行 股 本（發 行 認 購 股 份 除 外）於 本 公 告 日 期 至 完 成 期 間 並 無 變 動， 緊隨完成後本公司經擴大已發行股本約16.67%。 – 1 – 認 購 事 項 之 所 得 款 項 淨 額（經 扣 除 所 有 相 關 開 支）將 約 為31.72百 萬 港 元，相 當 於每股 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 China Oral Industry Group Holdings Limited 中國口腔產業集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰8406） 委任聯席公司秘書 中 國 口 腔 產 業 集 團 控 股 有 限 公 司（「本公司」）董 事（「董 事」）會（「董事會」）欣 然 宣 佈，陳 樂 燕 女 士（「陳女士」）已 獲 委 任 為 本 公 司 聯 席 公 司 秘 書（「聯席公司秘書」）， 自 二 零 二 四 年 十 一 月 二 十 九 日 起 生 效。 陳 女 士 之 履 歷 詳 情 載 列 如 下： 於 陳 女 士 獲 委 任 後，本 公 司 的 聯 席 公 司 秘 書 為 陳 女 士 及 詹 麗 娟 女 士。 – 1 – 董 事 會 謹 此 歡 迎 陳 女 士 履 新。 承董事會命 中國口腔產業集團控股有限公司 主 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 China Oral Industry Group Holdings Limited 中國口腔產業集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰8406） 有關二零二三年年度報告之 補充公告 茲 提 述 中 國 口 腔 產 業 集 團 控 股 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 統 稱「本 集 團」）截 至 二 零 二 三 年 十 二 月 三 十 一 日 止 年 度 之 年 度 報 告（「年 報」）。除 另 有 界 定 者 外，本 公 告 所 用 詞 彙 與 年 報 所 界 定 者 具 有 相 同 涵 義。 董 事 會 謹 此 提 供 有 關 年 報 之 額 外 資 料。 配售籌集資金之所得款項用途 於 二 零 二 二 年 十 月 二 十 一 日，本 公 司 與 中 國 北 方 證 券 集 團 有 限 公 司（ ...

Financial Performance - The company reported revenue of RMB 124.66 million for the six months ended June 30, 2024, representing a 31.3% increase from RMB 94.88 million in the same period of 2023[7]. - Gross profit for the same period was RMB 23.40 million, up 75.8% from RMB 13.34 million year-on-year[7]. - The net profit for the period was RMB 0.88 million, a significant recovery from a net loss of RMB 3.58 million in the previous year[7]. - The company achieved a basic and diluted earnings per share of RMB 0.08, recovering from a loss per share of RMB 0.37 in the previous year[7]. - The pre-tax profit for the six months ended June 30, 2024, was RMB 1,151,000, compared to a pre-tax loss of RMB 3,359,000 for the same period in 2023[19][20]. - The net profit attributable to the company's owners for the six months ended June 30, 2024, was RMB 880,000, compared to a loss of RMB 3.58 million in the same period of 2023[33]. - The group reported a profit of approximately RMB 880,000, an increase of about RMB 4,464,000 or 124.6% compared to a loss in the corresponding period in 2023 (RMB 3,584,000)[53]. Assets and Liabilities - Total assets increased to RMB 236.17 million as of June 30, 2024, compared to RMB 183.78 million at the end of 2023, marking a growth of 28.5%[8]. - The company's current liabilities rose to RMB 100.84 million, up from RMB 67.47 million at the end of 2023, indicating increased operational activity[8]. - The total liabilities as of June 30, 2024, were RMB 110,048,000, up from RMB 79,110,000 as of December 31, 2023, reflecting an increase of approximately 39.1%[22][23]. - The net asset value increased to RMB 126.12 million as of June 30, 2024, compared to RMB 104.67 million at the end of 2023, reflecting a growth of 20.5%[9]. - As of June 30, 2024, the total equity attributable to owners of the company reached RMB 126,121 thousand, an increase from RMB 123,148 thousand as of January 1, 2023, reflecting a growth of approximately 2.4%[10]. - As of June 30, 2024, the total equity attributable to the owners of the company was approximately RMB 126,121,000, up from RMB 104,665,000 as of December 31, 2023[55]. Cash Flow and Operating Activities - The net cash generated from operating activities for the six months ended June 30, 2024, was RMB 2,291 thousand, compared to RMB 22,683 thousand for the same period in 2023, indicating a significant decline of approximately 89.9%[11]. - The company’s operating cash flow before changes in working capital was RMB 2,331 thousand for the six months ended June 30, 2024, compared to a negative RMB 735 thousand for the same period in 2023[11]. - Cash and cash equivalents at the end of June 30, 2024, amounted to RMB 72,039 thousand, an increase from RMB 69,923 thousand at the end of June 30, 2023, representing a growth of approximately 3.0%[11]. - The company’s investment activities generated a net cash inflow of RMB 16,850 thousand for the six months ended June 30, 2024, compared to RMB 19,204 thousand for the same period in 2023, reflecting a decrease of approximately 6.9%[11]. Revenue Breakdown - The revenue breakdown includes RMB 103,126,000 from inflatable products, RMB 7,092,000 from dental clinic services, and RMB 14,003,000 from yarn and polyester sales[25]. - Revenue from the sale of inflatable products and related accessories was approximately RMB 103.57 million, up RMB 13.77 million or 15.3% from RMB 89.79 million in the previous year[46]. - Revenue from dental clinic services increased to approximately RMB 7.09 million, a rise of RMB 2.00 million or 39.3% compared to RMB 5.09 million in 2023[46]. - For the six months ended June 30, 2024, the total revenue from external customers was RMB 124,660,000, representing an increase from RMB 94,882,000 for the same period in 2023, which is a growth of approximately 31.3%[25]. Expenses and Costs - The cost of sales for the period was approximately RMB 101.26 million, an increase of RMB 19.71 million or 24.2% from RMB 81.54 million in the same period last year[47]. - Distribution and selling expenses amounted to approximately RMB 12,483,000, an increase of about RMB 2,167,000 or 21.0% compared to the corresponding period in 2023 (RMB 10,316,000)[50]. - Administrative expenses were approximately RMB 10,466,000, an increase of about RMB 1,278,000 or 13.9% compared to the corresponding period in 2023 (RMB 9,188,000)[51]. - Financial costs were approximately RMB 558,000, a decrease of about RMB 77,000 or 12.1% compared to the corresponding period in 2023 (RMB 635,000) mainly due to reduced interest on lease liabilities[52]. Strategic Initiatives - The company plans to expand its market presence and invest in new product development to drive future growth[7]. - The company is focusing on enhancing its distribution and sales strategies to improve operational efficiency and profitability[7]. - The company has maintained its risk management policies without significant changes since the end of the last fiscal year[16]. - The company aims to attract and retain valuable talent through its stock option plan, which is designed to reward contributions to the group[66]. Corporate Governance - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited financial results for the period and confirmed compliance with applicable accounting standards and GEM listing rules[71]. - The company has adhered to the corporate governance code as per GEM listing rules during the reporting period[70]. - The board of directors has confirmed compliance with the trading standards for securities transactions during the reporting period[68]. Acquisitions and Investments - The company acquired 100% equity of Hong Kong Shengke Holdings Limited and Hong Kong Taixing Holdings Limited in 2023 and 2024, respectively, expanding its business into dental clinic operations and polyester sales[45]. - The group completed the acquisition of 100% equity in Hong Kong Tai Hing Holdings Limited in January 2024, which engages in yarn and polyester sales in China[56]. - The company reported no acquisitions of intangible assets during the period, compared to RMB 27,000 in the previous year[36]. Employee Information - As of June 30, 2024, the group had 567 full-time employees, with total employee compensation of approximately RMB 26,096,000, an increase from RMB 22,530,000 in 2023[62].

Financial Performance - The company reported its interim results for the six months ending June 30, 2024, with a focus on financial performance and operational metrics[1]. - The company's revenue for the six months ended June 30, 2024, was RMB 124.66 million, an increase of 31.3% compared to RMB 94.88 million for the same period in 2023[9]. - Gross profit for the same period was RMB 23.40 million, up from RMB 13.34 million, reflecting a gross margin improvement[9]. - The net profit for the period was RMB 0.88 million, a significant recovery from a net loss of RMB 3.58 million in the previous year[9]. - The company reported a total comprehensive income of RMB 1.84 million for the period, compared to a total comprehensive loss of RMB 2.29 million in the same period last year[9]. - The pre-tax profit for the six months ended June 30, 2024, was RMB 1,151,000, compared to a pre-tax loss of RMB 3,359,000 for the same period in 2023, indicating a significant turnaround[21][22]. - The company reported a profit of RMB 880 thousand for the six months ended June 30, 2024, compared to a loss of RMB 3,584 thousand in the same period of 2023[35]. - The overall gross margin for the period was approximately 18.8%, an increase of 4.7% from 14.1% in the previous year[50]. Revenue Breakdown - Revenue from the inflatable products segment was RMB 103,565,000, accounting for 83% of total revenue, while the dental clinic segment generated RMB 7,092,000, and the yarn and polyester segment contributed RMB 14,003,000[21]. - Revenue from external customers in North America was RMB 78,594 thousand, representing a 13.5% increase from RMB 69,192 thousand in the previous year[29]. - Revenue from the sale of inflatable products and related accessories was approximately RMB 103.57 million, up RMB 13.77 million or 15.3% from RMB 89.79 million in the previous year[48]. Assets and Liabilities - The total assets increased to RMB 236.17 million as of June 30, 2024, compared to RMB 183.78 million at the end of 2023, representing a growth of 28.5%[10]. - Total liabilities increased to RMB 110,048 thousand as of June 30, 2024, compared to RMB 79,110 thousand at the end of 2023[24][25]. - Current liabilities rose to RMB 100.84 million, up from RMB 67.47 million at the end of 2023, indicating increased operational activity[10]. - Trade receivables as of June 30, 2024, were RMB 40,652 thousand, significantly higher than RMB 17,707 thousand at the end of 2023[39]. - The total current assets as of June 30, 2024, amounted to approximately RMB 126.12 million, compared to RMB 104.67 million on December 31, 2023[57]. Corporate Governance and Compliance - The company emphasizes compliance with the GEM listing rules and the importance of accurate and complete disclosures[2]. - The board of directors has confirmed the accuracy of the information presented, ensuring no misleading or fraudulent elements are included[2]. - The company is committed to transparency and accountability in its financial reporting and corporate governance practices[2]. - The Audit Committee was established on June 20, 2017, consisting of three independent non-executive directors, with Ms. Lian Jingyu as the chairperson[73]. - The Audit Committee reviewed the unaudited financial performance for the six months ending June 30, 2024, ensuring compliance with applicable accounting standards and GEM listing rules[73]. Future Outlook - Future outlook and performance guidance will be addressed in the full interim report, which is anticipated to be sent to shareholders[1]. - Market expansion strategies and potential mergers or acquisitions are likely to be discussed in the upcoming full report[1]. - The company is actively engaged in new product and technology development, although specific details were not provided in the content[1]. - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the report[9]. Employee and Compensation - The total employee compensation for the six months ended June 30, 2024, was approximately RMB 26,096,000, an increase from RMB 22,530,000 in the same period of 2023[64]. - As of June 30, 2024, the company had 567 full-time employees, up from 544 as of December 31, 2023[64]. Financial Management - The company has not made any significant changes to its liquidity risk management policies since the end of the previous fiscal year[18]. - The financial risk management policies remain unchanged since the end of the last fiscal year, addressing interest rate risk, credit risk, and liquidity risk[17]. - The company faces foreign exchange risk due to revenue being primarily denominated in USD while production costs are in RMB, with no formal foreign exchange hedging policy in place[62]. Miscellaneous - The company did not declare any interim dividend for the six months ended June 30, 2024, consistent with the previous year[36]. - The company has not granted any stock options under its stock option plan since its adoption on November 15, 2017[68]. - No purchases, sales, or redemptions of the company's securities occurred during the reporting period[71].

Financial Performance - The company reported a total revenue of approximately RMB 166,917,000 for 2023, a decrease of about RMB 45,602,000 or 21.5% compared to 2022[17]. - Revenue from the sale of inflatable products and related accessories was approximately RMB 151,177,000, down RMB 61,342,000 or 28.9% from RMB 212,519,000 in 2022[12]. - The company generated revenue of RMB 9,695,000 from dental clinic services and RMB 6,045,000 from the sale of medical equipment and dental materials, accounting for approximately 5.8% and 3.6% of total revenue, respectively[12]. - The group recorded revenue from overseas customers of approximately RMB 140,136,000, accounting for 84.0% of total revenue, a decrease from 95.3% in the previous year[79]. - Total revenue from the group's top five customers contributed approximately 60.7% of total revenue, slightly down from 60.8% in the previous year[79]. Profit and Loss - The company incurred a loss of approximately RMB 18,626,000 for the year, a reduction of about RMB 16,225,000 or 46.6% compared to a loss of RMB 34,851,000 in 2022[12]. - The group reported a loss of approximately RMB 18,626,000 for the year, a decrease of approximately RMB 16,225,000 or 46.6% compared to the loss of RMB 34,851,000 in 2022[29]. - Other income and gains totaled approximately RMB 5,468,000 in 2023, a decrease of approximately RMB 3,345,000 or 38.0% from 2022 (RMB 8,813,000) primarily due to reduced rental income and subsidies[23]. Cost and Expenses - The cost of sales for 2023 was approximately RMB 139,882,000, a decrease of about RMB 55,066,000 or 28.2% from RMB 194,948,000 in 2022[19]. - Distribution and selling expenses amounted to approximately RMB 20,174,000 in 2023, a decrease of approximately RMB 3,287,000 or 14.0% from 2022 (RMB 23,461,000)[24]. - Administrative expenses were approximately RMB 19,593,000 in 2023, down by approximately RMB 4,572,000 or 18.9% from 2022 (RMB 24,165,000)[25]. Acquisitions and Investments - The company completed the acquisition of Hong Kong Shengke Holdings Limited in January 2023, which is expected to provide new revenue sources in the dental care industry[16]. - The group completed the acquisition of Hong Kong Shengke Holdings Limited and its subsidiaries in January 2023[37]. - The group plans to acquire Hong Kong Taixing Holdings Limited and its subsidiaries for HKD 25,600,000, with the transaction completed on January 29, 2024[42]. - The company’s management is still determining the financial impact of the acquisition of Hong Kong Tai Hing Holdings Limited as of the approval date of the financial statements[129]. Equity and Capital - As of December 31, 2023, the group's total equity attributable to owners was approximately RMB 104,665,000, down from RMB 123,148,000 in 2022[31]. - Capital expenditure for the year was approximately RMB 1,842,000, an increase from RMB 616,000 in 2022[32]. - The company’s distributable reserves as of December 31, 2023, were approximately RMB 34,225,000, down from RMB 61,438,000 in 2022[94]. Employee and Compensation - The total employee compensation for the group in 2023 was approximately RMB 42,001,000, down from approximately RMB 50,993,000 in 2022, with a total of 544 full-time employees as of December 31, 2023[48]. - The company's remuneration policy includes fixed components (base salary) and variable components (discretionary bonuses and other rewards)[120]. - The board of directors and senior management's remuneration is reviewed annually by the remuneration committee[120]. Corporate Governance - The board of directors is committed to maintaining high standards of corporate governance to protect shareholder interests and enhance group performance[141]. - The company has established a referral agreement with Mango Financial Limited to introduce potential clients for the bond issuance[130]. - The audit committee held 5 meetings during the year to review the company's annual and interim performance, ensuring compliance with applicable accounting standards and GEM listing rules[159]. - The board aims to maintain at least 66.7% female representation among directors, 50% among senior management, and 62.7% among other employees[189]. Risk Management - The group faces risks related to fluctuations in the RMB to USD exchange rate and potential product liability claims[73]. - The group has not established an internal audit function as of December 31, 2023, but will continue to evaluate the need for such a function annually[176]. - There were no significant legal or regulatory non-compliance issues affecting the group's business operations during the reporting period[196]. Quality and Standards - The company emphasizes high-quality standards and strict quality control procedures in its production processes[16]. - The group emphasizes quality control, product safety, and customer service as critical to maintaining customer trust[79]. - The company believes that its product design and development capabilities will enhance competitiveness through product differentiation and innovation[16]. Shareholder Communication - The company has established multiple channels for shareholder communication to ensure timely and unbiased information dissemination[197]. - The company confirmed that it has maintained the public float required by GEM listing rules as of the date of the annual report[135].